Patient Access Network Foundation launches new chemotherapy-induced nausea and vomiting patient assistance fund

For immediate release

PAN Foundation contact:
Margaret Figley, Director of Communications
Phone: 202-661-8074

Washington, DC, May 24, 2016 – The Patient Access Network (PAN) Foundation today announced the launch of a new patient assistance program for Medicare patients experiencing chemotherapy-induced nausea and vomiting (CINV). Qualifying patients are eligible to receive grants for their out-of-pocket costs associated with their prescribed CINV medications.
“The PAN Foundation is pleased to help people experiencing chemotherapy-induced nausea and vomiting,” said PAN President and CEO Daniel Klein. “We are committed to finding ways to ease the financial burdens on people experiencing nausea and vomiting as a result of their chemotherapy, so that they can focus on feeling better, getting through their treatments and hopefully recovering from their cancer.”
To qualify for assistance from the PAN Foundation, patients experiencing CINV must have Medicare insurance and it must cover the medication for which they seek assistance. To be eligible, patients also must reside and receive treatment in the United States and have a household income at or below 400 percent of the Federal Poverty Level ($79,650 or less for a family of two).
Patients, or advocates and caregivers applying on their behalf, can apply for assistance using PAN’s patient portal ( or by calling 1-866-316-7263, 9 a.m. to 5 p.m. Eastern Time, Monday through Friday.

For more information about the PAN Foundation, visit

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)(3) organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $1 billion in financial assistance to more than half a million patients who would otherwise be unable to afford their medications. To learn more, visit